Now we know why TSOI CEO Dixon has such a tremendous IP portfolio and big board executives already on TSOI's BOD's and Advisory Board right LTT buddy!
Plus we also have another significant dot connected as to why CEO Dixon recently informed us shareholders that there would be ZERO dilution required to pay for JadiCell Phase III human clinical trials right!
And we've also already seen multiple references in recent TSOI PR's about potential "collaborators" aka partners right buddy!
So when I say TSOI isn't some typical run of the mill penny stock I really mean it, because the foundation couldn't be any better set for all the REAL DEAL bio sector shock & awe catalysts approaching cheers;)
News 
Market Data 
Discover 
